iBio (IBIO) Institutional Ownership → Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad) Free IBIO Stock Alerts $2.42 +0.23 (+10.50%) (As of 05/28/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for iBio (NYSE:IBIO)CurrentInstitutional OwnershipPercentage7.90%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.44MNumber ofInstitutional Sellers(last 12 months)0 Get IBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling iBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Chaikin AnalyticsWall Street Legend Warns: "A Strange Day Is Coming to America"Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.Click here to learn more. iBio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Ikarian Capital LLC600,000$2.44M0.3%N/A6.961% (Data available from 1/1/2016 forward) IBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IBIO shares? During the previous two years, the following institutional investors and hedge funds held shares of iBio shares: Ikarian Capital LLC ($2.44M).Learn more on IBIO's institutional investors. What percentage of iBio stock is owned by institutional investors? 7.90% of iBio stock is owned by institutional investors. Learn more on IBIO's institutional investor holdings. Which institutional investors have been buying iBio stock? The following institutional investors have purchased iBio stock in the last 24 months: Ikarian Capital LLC ($600K). How much institutional buying is happening at iBio? Institutional investors have bought a total of 600,000 shares in the last 24 months. This purchase volume represents approximately $2.44M in transactions. Related Companies: INDP Major Shareholders LUMO Major Shareholders APM Major Shareholders MEIP Major Shareholders SYBX Major Shareholders BIVI Major Shareholders FBRX Major Shareholders VBIV Major Shareholders KALA Major Shareholders SLGL Major Shareholders This page (NYSE:IBIO) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
